Fred Alger Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,241
Closed -$139K 541
2022
Q4
$139K Buy
+6,241
New +$139K ﹤0.01% 439